Exact Mass: 402.1077

Exact Mass Matches: 402.1077

Found 81 metabolites which its exact mass value is equals to given mass value 402.1077, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid-O-glucuronide

(2S,3S,4S,5R,6S)-6-{[5-(3,4-dihydroxyphenyl)-4-hydroxypentanoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H22O11 (402.1162)


4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid-O-glucuronide is a conjugate of 4-hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid-O-glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. (Wikipedia)

   

4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid-O-glucuronide

(2S,3S,4S,5R,6S)-6-{[5-(3,5-dihydroxyphenyl)-4-hydroxypentanoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H22O11 (402.1162)


4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid-O-glucuronide is a conjugate of 4-hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid and glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. (Wikipedia)

   

6-[4-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[4-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H22O11 (402.1162)


6-[4-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 5-(3,4-dihydroxyphenyl)-4-hydroxypentanoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-[5-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[5-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H22O11 (402.1162)


6-[5-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 5-(3,4-dihydroxyphenyl)-4-hydroxypentanoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid glucuronide

(2S,4S,6S)-6-[3-(4-carboxy-2-hydroxybutyl)-5-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H22O11 (402.1162)


   

Apodanthoside

Apodanthoside

C17H22O11 (402.1162)


   

10-Dehydrogardenoside

10-Dehydrogardenoside

C17H22O11 (402.1162)


   

8-p-Coumaroyl-3,4-dihydro-5,7-dihydroxy-4-phenylcoumarin

8-p-Coumaroyl-3,4-dihydro-5,7-dihydroxy-4-phenylcoumarin

C24H18O6 (402.1103)


   

Calomelanol I

3,4,7,8-Tetrahydro-5-hydroxy-4- (4-hydroxyphenyl) -8-phenyl-2H,6H-benzo [ 1,2-b:5,4-b ] dipyran-2,6-dione

C24H18O6 (402.1103)


   

Calomelanol H

3,4,7,8-Tetrahydro-5-hydroxy-8- (4-hydroxyphenyl) -4-phenyl-2H,6H-benzo [ 1,2-b:5,4-b ] dipyran-2,6-dione

C24H18O6 (402.1103)


   

Ethylidene-3,6-biplumbagin

Ethylidene-3,6-biplumbagin

C24H18O6 (402.1103)


   

Saptomycin F

Saptomycin F

C24H18O6 (402.1103)


   

Pinobanksin 3-cinnamate

Pinobanksin 3-cinnamate

C24H18O6 (402.1103)


   
   
   

Apodanthoside (Not validated)

Apodanthoside (Not validated)

C17H22O11 (402.1162)


Annotation level-3

   

Di-Me ether-Neodiospyrin

Di-Me ether-Neodiospyrin

C24H18O6 (402.1103)


   

Ohioensin D

Ohioensin D

C24H18O6 (402.1103)


   

Ixoside, 10-methyl

Ixoside, 10-methyl

C17H22O11 (402.1162)


   

3,3-Ethylidenebis(2-methyl-5-hydroxy-1,4-naphthoquinone)

3,3-Ethylidenebis(2-methyl-5-hydroxy-1,4-naphthoquinone)

C24H18O6 (402.1103)


   

3,6-Ethylidenebis(2-methyl-5-hydroxy-1,4-naphthoquinone)

3,6-Ethylidenebis(2-methyl-5-hydroxy-1,4-naphthoquinone)

C24H18O6 (402.1103)


   

1-O,2-O-[(1S,2S)-1-(3-acetyl-2,4,6-trihydroxyphenyl)-3-hydroxypropane-1,2-diyl]-beta-D-glucopyranose|1-O,2-O-[(1S,2S)-1-(3-acetyl-2,4,6-trihydroxyphenyl)-3-hydroxypropane-1,3-diyl]-beta-D-glucopyranose|tomentoside II

1-O,2-O-[(1S,2S)-1-(3-acetyl-2,4,6-trihydroxyphenyl)-3-hydroxypropane-1,2-diyl]-beta-D-glucopyranose|1-O,2-O-[(1S,2S)-1-(3-acetyl-2,4,6-trihydroxyphenyl)-3-hydroxypropane-1,3-diyl]-beta-D-glucopyranose|tomentoside II

C17H22O11 (402.1162)


   

DTXSID60518878

DTXSID60518878

C24H18O6 (402.1103)


   

Di-Me ether-Maritinone

Di-Me ether-Maritinone

C24H18O6 (402.1103)


   

ixoside 11-methyl ester

ixoside 11-methyl ester

C17H22O11 (402.1162)


   

ethylidene-6,6-biplumbagin

ethylidene-6,6-biplumbagin

C24H18O6 (402.1103)


   

4-Methoxy-benzoic acid 4-(4-methoxy-phenyl)-2-oxo-2H-chromen-7-yl ester

NCGC00160346-01!4-Methoxy-benzoic acid 4-(4-methoxy-phenyl)-2-oxo-2H-chromen-7-yl ester

C24H18O6 (402.1103)


   

HoPhe-Asp-OH

(S)-2-(4-nitro-3-phenethoxybenzamido)pentanedioic acid

C19H18N2O8 (402.1063)


   

Asp-HoPhe-OH

(S)-2-(3-(carboxymethoxy)-4-nitrobenzamido)-5-phenylpentanoic acid

C19H18N2O8 (402.1063)


   
   

4-Biphenylyl diphenyl phosphate

4-Biphenylyl diphenyl phosphate

C24H19O4P (402.1021)


   

2-Biphenylyl diphenyl phosphate suppliers in China

2-Biphenylyl diphenyl phosphate suppliers in China

C24H19O4P (402.1021)


   

5-O-CARBOMETHOXY-1,2-O-ISO-PROPYLIDENE-3-O-(P-TOLYL-SULFONYL)-ALPHA-D-XYLOFURANOSE

5-O-CARBOMETHOXY-1,2-O-ISO-PROPYLIDENE-3-O-(P-TOLYL-SULFONYL)-ALPHA-D-XYLOFURANOSE

C17H22O9S (402.0984)


   

4-[(4-Chlorophenyl) phenylmethyl]-piperidine dihydrochloride

4-[(4-Chlorophenyl) phenylmethyl]-piperidine dihydrochloride

C19H25Cl3N2O (402.1032)


   

Dimethyl 2,5-dibenzoylterephthalate

Dimethyl 2,5-dibenzoylterephthalate

C24H18O6 (402.1103)


   

DISPERSE RED 13 ACRYLATE

DISPERSE RED 13 ACRYLATE

C19H19ClN4O4 (402.1095)


   

1,2-BIS(DI(PYRIDIN-2-YL)PHOSPHINO)ETHANE

1,2-BIS(DI(PYRIDIN-2-YL)PHOSPHINO)ETHANE

C22H20N4P2 (402.1163)


   

3-Deoxy-3-fluoro-beta-D-ribofuranose 1-acetate 2,5-dibenzoate

3-Deoxy-3-fluoro-beta-D-ribofuranose 1-acetate 2,5-dibenzoate

C21H19FO7 (402.1115)


   

4-[[[2-(4-Methoxyphenyl)-3-thiazolidinyl]-sulfanylidenemethyl]amino]benzoic acid ethyl ester

4-[[[2-(4-Methoxyphenyl)-3-thiazolidinyl]-sulfanylidenemethyl]amino]benzoic acid ethyl ester

C20H22N2O3S2 (402.1072)


   

4-(4-methoxyphenyl)-2-oxo-2H-chromen-7-yl 4-methoxybenzoate

4-(4-methoxyphenyl)-2-oxo-2H-chromen-7-yl 4-methoxybenzoate

C24H18O6 (402.1103)


   
   
   

4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid glucuronide

4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid glucuronide

C17H22O11 (402.1162)


   
   

4-Chloro-3-(1-pyrrolidinylsulfonyl)benzoic acid [2-(butylamino)-2-oxoethyl] ester

4-Chloro-3-(1-pyrrolidinylsulfonyl)benzoic acid [2-(butylamino)-2-oxoethyl] ester

C17H23ClN2O5S (402.1016)


   

3-[[[2-(3-Methylphenyl)-4-quinolinyl]-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester

3-[[[2-(3-Methylphenyl)-4-quinolinyl]-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester

C23H18N2O3S (402.1038)


   

(1R,9aR)-octahydro-2H-quinolizin-1-ylmethyl (4-chlorophenoxy)sulfonylcarbamate

(1R,9aR)-octahydro-2H-quinolizin-1-ylmethyl (4-chlorophenoxy)sulfonylcarbamate

C17H23ClN2O5S (402.1016)


   

4-[[[4-(2-Furanylmethyl)-5-(3-methoxyphenyl)-1,2,4-triazol-3-yl]thio]methyl]benzonitrile

4-[[[4-(2-Furanylmethyl)-5-(3-methoxyphenyl)-1,2,4-triazol-3-yl]thio]methyl]benzonitrile

C22H18N4O2S (402.115)


   

6-[5-(3,4-Dihydroxyphenyl)-4-hydroxypentanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[5-(3,4-Dihydroxyphenyl)-4-hydroxypentanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H22O11 (402.1162)


   

4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid-O-glucuronide

4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid-O-glucuronide

C17H22O11 (402.1162)


   

4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid-O-glucuronide

4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid-O-glucuronide

C17H22O11 (402.1162)


   

6-[4-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[4-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H22O11 (402.1162)


   

6-[5-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[5-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H22O11 (402.1162)


   

N-(4-chlorophenoxy)sulfonylcarbamic acid [(1R,9aR)-2,3,4,6,7,8,9,9a-octahydro-1H-quinolizin-1-yl]methyl ester

N-(4-chlorophenoxy)sulfonylcarbamic acid [(1R,9aR)-2,3,4,6,7,8,9,9a-octahydro-1H-quinolizin-1-yl]methyl ester

C17H23ClN2O5S (402.1016)


   

Fuzapladib (sodium)

Fuzapladib (sodium)

C15H20F3N3NaO3S (402.1075)


Fuzapladib (IS-741) sodium, an orally active leukocyte-function-associated antigen type 1 (LFA-1) activation inhibitor, is a leukocyte adhesion molecule. Fuzapladib sodium is also a phospholipase A2 (PLA2) inhibitor. Fuzapladib sodium exerts anti-inflammatory effects by inhibiting leukocyte migration into the inflammatory site[1][2].

   

VU-1545

VU-1545

C22H15FN4O3 (402.1128)


VU-1545 is a metabotropic glutamate receptor 5 positive allosteric modulator (mGluR5 PAM) with a Ki of 156 nM and an EC50 of 9.6 nM[1].

   

11-hydroxy-5-methyl-2-[(2r,3s)-2-methyl-3-[(1e)-prop-1-en-1-yl]oxiran-2-yl]-1-oxatetraphene-4,7,12-trione

11-hydroxy-5-methyl-2-[(2r,3s)-2-methyl-3-[(1e)-prop-1-en-1-yl]oxiran-2-yl]-1-oxatetraphene-4,7,12-trione

C24H18O6 (402.1103)


   

5-hydroxy-6-[1-(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione

5-hydroxy-6-[1-(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione

C24H18O6 (402.1103)


   

methyl (1s,4as,7s,7as)-7-formyl-7-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1s,4as,7s,7as)-7-formyl-7-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylate

C17H22O11 (402.1162)


   

(3r,5as,6s,10ar)-3-benzyl-1,6-dihydroxy-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indol-4-one

(3r,5as,6s,10ar)-3-benzyl-1,6-dihydroxy-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indol-4-one

C20H22N2O3S2 (402.1072)


   

(1s,4as,7s,7as)-4-(methoxycarbonyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid

(1s,4as,7s,7as)-4-(methoxycarbonyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid

C17H22O11 (402.1162)


   

4-(methoxycarbonyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid

4-(methoxycarbonyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid

C17H22O11 (402.1162)


   

methyl 7-formyl-7-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylate

methyl 7-formyl-7-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylate

C17H22O11 (402.1162)


   

5-hydroxy-6-[1-(1-hydroxy-6-methyl-5,8-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione

5-hydroxy-6-[1-(1-hydroxy-6-methyl-5,8-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione

C24H18O6 (402.1103)


   

3-benzyl-1,6-dihydroxy-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indol-4-one

3-benzyl-1,6-dihydroxy-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indol-4-one

C20H22N2O3S2 (402.1072)


   

(7s,13r)-9-hydroxy-7-(4-hydroxyphenyl)-13-phenyl-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1,3(8),9-triene-5,11-dione

(7s,13r)-9-hydroxy-7-(4-hydroxyphenyl)-13-phenyl-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1,3(8),9-triene-5,11-dione

C24H18O6 (402.1103)


   

(7r,13s)-9-hydroxy-13-(4-hydroxyphenyl)-7-phenyl-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1,3(8),9-triene-5,11-dione

(7r,13s)-9-hydroxy-13-(4-hydroxyphenyl)-7-phenyl-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1,3(8),9-triene-5,11-dione

C24H18O6 (402.1103)


   

11-hydroxy-5-methyl-2-{2-methyl-3-[(1z)-prop-1-en-1-yl]oxiran-2-yl}-1-oxatetraphene-4,7,12-trione

11-hydroxy-5-methyl-2-{2-methyl-3-[(1z)-prop-1-en-1-yl]oxiran-2-yl}-1-oxatetraphene-4,7,12-trione

C24H18O6 (402.1103)


   

9-hydroxy-7-(4-hydroxyphenyl)-13-phenyl-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1,3(8),9-triene-5,11-dione

9-hydroxy-7-(4-hydroxyphenyl)-13-phenyl-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1,3(8),9-triene-5,11-dione

C24H18O6 (402.1103)


   

(1s,4as,7as)-7-(methoxycarbonyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,7as)-7-(methoxycarbonyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C17H22O11 (402.1162)


   

methyl (1s,4ar,7r,7as)-7-formyl-7-hydroxy-1-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1s,4ar,7r,7as)-7-formyl-7-hydroxy-1-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylate

C17H22O11 (402.1162)


   

5,6,11-trihydroxy-9-methoxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2(7),3,5,8(24),9,11,16,18,20-nonaen-13-one

5,6,11-trihydroxy-9-methoxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2(7),3,5,8(24),9,11,16,18,20-nonaen-13-one

C24H18O6 (402.1103)


   

1-{3-[(2s,3s,4ar,6r,7s,8s,8ar)-7,8-dihydroxy-2,6-bis(hydroxymethyl)-hexahydro-2h-pyrano[2,3-b][1,4]dioxin-3-yl]-2,4,6-trihydroxyphenyl}ethanone

1-{3-[(2s,3s,4ar,6r,7s,8s,8ar)-7,8-dihydroxy-2,6-bis(hydroxymethyl)-hexahydro-2h-pyrano[2,3-b][1,4]dioxin-3-yl]-2,4,6-trihydroxyphenyl}ethanone

C17H22O11 (402.1162)


   

(1r,15s,23s)-5,6,11-trihydroxy-9-methoxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2(7),3,5,8(24),9,11,16,18,20-nonaen-13-one

(1r,15s,23s)-5,6,11-trihydroxy-9-methoxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2(7),3,5,8(24),9,11,16,18,20-nonaen-13-one

C24H18O6 (402.1103)


   

5-hydroxy-3-[1-(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione

5-hydroxy-3-[1-(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione

C24H18O6 (402.1103)


   

(1s,4as,7as)-7-(methoxycarbonyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,7as)-7-(methoxycarbonyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C17H22O11 (402.1162)


   

4-(methoxycarbonyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid

4-(methoxycarbonyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid

C17H22O11 (402.1162)


   

11-hydroxy-5-methyl-2-[2-methyl-3-(prop-1-en-1-yl)oxiran-2-yl]-1-oxatetraphene-4,7,12-trione

11-hydroxy-5-methyl-2-[2-methyl-3-(prop-1-en-1-yl)oxiran-2-yl]-1-oxatetraphene-4,7,12-trione

C24H18O6 (402.1103)


   

5-hydroxy-6-[(1s)-1-(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione

5-hydroxy-6-[(1s)-1-(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione

C24H18O6 (402.1103)


   

(1r,4as,7r,7as)-4-(methoxycarbonyl)-1-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid

(1r,4as,7r,7as)-4-(methoxycarbonyl)-1-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid

C17H22O11 (402.1162)


   

7-(methoxycarbonyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

7-(methoxycarbonyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C17H22O11 (402.1162)